Our balanced research and development portfolio is divided
into three categories: life cycle management, market
development and new product development.

Lifecycle management ensures continuous product improvement by maintaining and increasing competitiveness within our existing product range.
Market development brings therapies to new markets and new indications by maximizing market opportunities for our existing product range.
New product development creates specialty therapies to treat life-threatening diseases. It ensures long-term growth primarily through projects aligned with our current marketing channels.

Rollover each product in development to learn more.